- Home
- PBYI vs EVC Comparison
PBYI vs EVC Comparison
Compare PBYI & EVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- EVC
- Stock Information
- Founded
- PBYI 2010
- EVC 1996
- Country
- PBYI United States
- EVC United States
- Employees
- PBYI N/A
- EVC N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- EVC Broadcasting
- Sector
- PBYI Health Care
- EVC Industrials
- Exchange
- PBYI Nasdaq
- EVC Nasdaq
- Market Cap
- PBYI 164.3M
- EVC 188.3M
- IPO Year
- PBYI N/A
- EVC 2000
- Fundamental
- Price
- PBYI $3.54
- EVC $2.45
- Analyst Decision
- PBYI Strong Buy
- EVC
- Analyst Count
- PBYI 1
- EVC 0
- Target Price
- PBYI $7.00
- EVC N/A
- AVG Volume (30 Days)
- PBYI 306.9K
- EVC 352.0K
- Earning Date
- PBYI 07-31-2025
- EVC 08-07-2025
- Dividend Yield
- PBYI N/A
- EVC 8.16%
- EPS Growth
- PBYI 143.51
- EVC N/A
- EPS
- PBYI 0.77
- EVC N/A
- Revenue
- PBYI $232,709,000.00
- EVC $378,623,000.00
- Revenue This Year
- PBYI N/A
- EVC $64.06
- Revenue Next Year
- PBYI N/A
- EVC N/A
- P/E Ratio
- PBYI $4.64
- EVC N/A
- Revenue Growth
- PBYI 2.68
- EVC 23.10
- 52 Week Low
- PBYI $2.23
- EVC $1.58
- 52 Week High
- PBYI $4.13
- EVC $2.73
- Technical
- Relative Strength Index (RSI)
- PBYI 58.61
- EVC 63.90
- Support Level
- PBYI $3.26
- EVC $2.19
- Resistance Level
- PBYI $3.65
- EVC $2.46
- Average True Range (ATR)
- PBYI 0.14
- EVC 0.12
- MACD
- PBYI 0.01
- EVC 0.01
- Stochastic Oscillator
- PBYI 84.78
- EVC 97.67
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About EVC Entravision Communications Corporation
Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.